Nath Bio-Genes (India) Limited
Symbol: NATHBIOGEN.NS
NSE
195
INRMarktpreis heute
9.0886
P/E-Verhältnis
2.0302
PEG-Verhältnis
3.71B
MRK Kapital
- 0.02%
DIV Rendite
Nath Bio-Genes (India) Limited (NATHBIOGEN-NS) Finanzberichte
Bilanz
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 2089.2 | 41.7 | 292.1 | ||||||||||||
balance-sheet.row.short-term-investments | 0 | 1709.3 | 0.2 | 0 | ||||||||||||
balance-sheet.row.net-receivables | 0 | 1033.6 | 2456.6 | 2683.8 | ||||||||||||
balance-sheet.row.inventory | 0 | 2078.5 | 2203.4 | 2263 | ||||||||||||
balance-sheet.row.other-current-assets | 0 | 7 | 0 | 0 | ||||||||||||
balance-sheet.row.total-current-assets | 0 | 5208.3 | 4701.7 | 5238.9 | ||||||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 2339.6 | 2328.5 | 2333 | ||||||||||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | ||||||||||||
balance-sheet.row.intangible-assets | 0 | 104.2 | 120.3 | 136.2 | ||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 104.2 | 120.3 | 136.2 | ||||||||||||
balance-sheet.row.long-term-investments | 0 | 50.5 | 50.5 | 50.5 | ||||||||||||
balance-sheet.row.tax-assets | 0 | 0 | 218.1 | 136.5 | ||||||||||||
balance-sheet.row.other-non-current-assets | 0 | 225.4 | 0 | 0 | ||||||||||||
balance-sheet.row.total-non-current-assets | 0 | 2719.7 | 2717.4 | 2656.2 | ||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||||||||
balance-sheet.row.total-assets | 0 | 7928 | 7419.1 | 7895.1 | ||||||||||||
balance-sheet.row.account-payables | 0 | 277.4 | 550.9 | 452.3 | ||||||||||||
balance-sheet.row.short-term-debt | 0 | 1048.1 | 922.9 | 959.1 | ||||||||||||
balance-sheet.row.tax-payables | 0 | 2.8 | 8.9 | 25.3 | ||||||||||||
balance-sheet.row.long-term-debt-total | 0 | 4 | 6.6 | 6.5 | ||||||||||||
Deferred Revenue Non Current | 0 | 0 | 0 | 0 | ||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | ||||||||||||
balance-sheet.row.other-current-liab | 0 | 830.4 | 63.6 | 0 | ||||||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 31.7 | 32.8 | 32.3 | ||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 0 | 0 | 0 | ||||||||||||
balance-sheet.row.total-liab | 0 | 2196.2 | 1999.4 | 1762.3 | ||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | ||||||||||||
balance-sheet.row.common-stock | 0 | 190 | 190 | 190 | ||||||||||||
balance-sheet.row.retained-earnings | 0 | 4056.6 | 3744.7 | 4456.1 | ||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 150.1 | 149.9 | 151.6 | ||||||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 1335 | 1335 | 1335 | ||||||||||||
balance-sheet.row.total-stockholders-equity | 0 | 5731.7 | 5419.7 | 6132.8 | ||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 7928 | 7419.1 | 7895.1 | ||||||||||||
balance-sheet.row.minority-interest | 0 | -0.2 | 0 | 0 | ||||||||||||
balance-sheet.row.total-equity | 0 | 5731.5 | 5419.6 | 6132.8 | ||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | ||||||||||||
Total Investments | 0 | 50.5 | 50.6 | 50.5 | ||||||||||||
balance-sheet.row.total-debt | 0 | 1052.1 | 929.6 | 965.7 | ||||||||||||
balance-sheet.row.net-debt | 0 | 672.2 | 887.9 | 673.6 |
Kapitalflussrechnung
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | 361.6 | -633.9 | 567.5 | |||||||||||
cash-flows.row.depreciation-and-amortization | 0 | 30.1 | 30.8 | 28.2 | |||||||||||
cash-flows.row.deferred-income-tax | 0 | 0 | 0 | 0 | |||||||||||
cash-flows.row.stock-based-compensation | 0 | 0 | 0 | 0 | |||||||||||
cash-flows.row.change-in-working-capital | 0 | -98.1 | -180.7 | -651.3 | |||||||||||
cash-flows.row.account-receivables | 0 | -118.8 | 210.2 | -20.6 | |||||||||||
cash-flows.row.inventory | 0 | 125 | 59.6 | -219.9 | |||||||||||
cash-flows.row.account-payables | 0 | -150.5 | 199.9 | -229.7 | |||||||||||
cash-flows.row.other-working-capital | 0 | 46.2 | -650.4 | -181.1 | |||||||||||
cash-flows.row.other-non-cash-items | 0 | 90 | 954.2 | 66.7 | |||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | |||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -25.5 | -210.2 | -116 | |||||||||||
cash-flows.row.acquisitions-net | 0 | 0.5 | 0.7 | 1.5 | |||||||||||
cash-flows.row.purchases-of-investments | 0 | 0 | -0.2 | -0.5 | |||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | -0.5 | -0.7 | -1.5 | |||||||||||
cash-flows.row.other-investing-activites | 0 | -3.4 | 11.7 | 13.7 | |||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -28.8 | -198.7 | -102.8 | |||||||||||
cash-flows.row.debt-repayment | 0 | -122.5 | -78.2 | -252.2 | |||||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 0 | 0 | |||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | |||||||||||
cash-flows.row.dividends-paid | 0 | -38 | -38 | 0 | |||||||||||
cash-flows.row.other-financing-activites | 0 | 143.9 | -106.1 | 416.2 | |||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | -16.7 | -222.3 | 164 | |||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 0 | 0.1 | 0 | |||||||||||
cash-flows.row.net-change-in-cash | 0 | 338.1 | -250.5 | 72.3 | |||||||||||
cash-flows.row.cash-at-end-of-period | 0 | 380 | 41.7 | 292.2 | |||||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 41.8 | 292.2 | 219.8 | |||||||||||
cash-flows.row.operating-cash-flow | 0 | 383.7 | 170.5 | 11.1 | |||||||||||
cash-flows.row.capital-expenditure | 0 | -25.5 | -210.2 | -116 | |||||||||||
cash-flows.row.free-cash-flow | 0 | 358.2 | -39.7 | -104.9 |
Zeile der Gewinn- und Verlustrechnung
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 3326.2 | 3012.9 | 2783.6 | |||||||||||||
income-statement-row.row.cost-of-revenue | 0 | 1650.8 | 1345.9 | 1239.7 | |||||||||||||
income-statement-row.row.gross-profit | 0 | 1675.4 | 1667 | 1543.9 | |||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||||
income-statement-row.row.research-development | 0 | - | - | - | |||||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | |||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||
income-statement-row.row.other-expenses | 0 | 0 | 5.6 | 1 | |||||||||||||
income-statement-row.row.operating-expenses | 0 | 1209.4 | 1208.2 | 1197.4 | |||||||||||||
income-statement-row.row.cost-and-expenses | 0 | 2860.2 | 2554.1 | 2437 | |||||||||||||
income-statement-row.row.interest-income | 0 | 0 | 0.2 | 10.9 | |||||||||||||
income-statement-row.row.interest-expense | 0 | 91.1 | 101.2 | 101.3 | |||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||
income-statement-row.row.total-other-income-expensenet | 0 | -84.8 | -95.7 | -980 | |||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||||
income-statement-row.row.other-operating-expenses | 0 | 0 | 5.6 | 1 | |||||||||||||
income-statement-row.row.total-operating-expenses | 0 | -84.8 | -95.7 | -980 | |||||||||||||
income-statement-row.row.interest-expense | 0 | 91.1 | 101.2 | 101.3 | |||||||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 32.6 | 30.1 | 30.8 | |||||||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | |||||||||||||
income-statement-row.row.operating-income | 0 | 466 | 457.3 | 345.7 | |||||||||||||
income-statement-row.row.income-before-tax | 0 | 381.2 | 363.2 | -633.9 | |||||||||||||
income-statement-row.row.income-tax-expense | 0 | 19.5 | 11.5 | 39.5 | |||||||||||||
income-statement-row.row.net-income | 0 | 361.7 | 350.1 | -673.4 |
Häufig gestellte Frage
Wie hoch ist die Nath Bio-Genes (India) Limited (NATHBIOGEN.NS) Gesamtvermögen?
Nath Bio-Genes (India) Limited (NATHBIOGEN.NS) Gesamtvermögen ist 7927970000.000.
Wie hoch ist der Jahresumsatz des Unternehmens?
Der Jahresumsatz ist N/A.
Wie hoch ist die Gewinnspanne des Unternehmens?
Die Gewinnmarge des Unternehmens ist 0.528.
Wie hoch ist der freie Cashflow des Unternehmens?
Der freie Cashflow ist 3.442.
Wie hoch ist die Nettogewinnspanne des Unternehmens?
Die Nettogewinnmarge ist 0.121.
Wie hoch sind die Gesamteinnahmen des Unternehmens?
Der Gesamtertrag ist 0.147.
Was ist der Nath Bio-Genes (India) Limited (NATHBIOGEN.NS) nettogewinn (reingewinn)?
Der Nettogewinn (Nettoeinkommen) ist 361697000.000.
Wie hoch ist die Gesamtverschuldung des Unternehmens?
Die Gesamtverschuldung ist 1052123000.000.
Wie hoch ist der Betriebsaufwand?
Die Betriebsausgaben sind 1209402000.000.
Wie hoch ist der Bargeldbestand des Unternehmens?
Die Unternehmensliquidität ist 0.000.